Cargando…
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy
Ischaemic cardiomyopathy is an important cardiovascular condition that has differing pathophysiological substrates and clinical manifestations. Contemporary management involves the administration of heart failure pharmacotherapy and device therapy where indicated, which has good prognostic data to s...
Autores principales: | Briceno, Natalia, Perera, Divaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846708/ https://www.ncbi.nlm.nih.gov/pubmed/27115418 http://dx.doi.org/10.1007/s11886-016-0726-9 |
Ejemplares similares
-
Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023) -
How to select patients requiring coronary revascularisation using coronary physiology
por: Modi, Bhavik, et al.
Publicado: (2021) -
FLOWER-MI and the root of the problem with non-culprit revascularisation
por: Li Kam Wa, Matthew E, et al.
Publicado: (2021) -
Impaired autonomic function after incomplete revascularisation
por: Armstrong, Richard, et al.
Publicado: (2021) -
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019)